1. Home
  2. ONTF vs STRO Comparison

ONTF vs STRO Comparison

Compare ONTF & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ON24 Inc.

ONTF

ON24 Inc.

HOLD

Current Price

$8.11

Market Cap

347.2M

Sector

Technology

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$40.49

Market Cap

338.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONTF
STRO
Founded
1998
2003
Country
United States
United States
Employees
N/A
131
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
347.2M
338.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ONTF
STRO
Price
$8.11
$40.49
Analyst Decision
Hold
Buy
Analyst Count
2
9
Target Price
$8.10
$31.33
AVG Volume (30 Days)
986.7K
241.9K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
32.67
N/A
EPS
N/A
N/A
Revenue
$139,312,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.70
$0.67
52 Week High
$8.11
$39.94

Technical Indicators

Market Signals
Indicator
ONTF
STRO
Relative Strength Index (RSI) 67.87 75.76
Support Level $7.84 $0.78
Resistance Level N/A N/A
Average True Range (ATR) 0.02 2.93
MACD -0.01 0.27
Stochastic Oscillator 88.89 87.24

Price Performance

Historical Comparison
ONTF
STRO

About ONTF ON24 Inc.

ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others. Geographically, the company derives maximum revenue from United States, and also has its presence in EMEA and Other Countries.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: